Literature DB >> 28595519

T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.

Weijie Ma1, Xi Chen1, Yufeng Yuan1.   

Abstract

Entities:  

Keywords:  T cellular immunotherapies; hepatocellular carcinoma; tumor-associated antigen

Mesh：

Substances：

Year:  2017        PMID： 28595519     DOI： 10.2217/imt-2017-0053

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  3 in total

Review 1.  Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma.

Authors:  Laura Amicone; Alessandra Marchetti
Journal:  Transl Gastroenterol Hepatol       Date:  2018-05-02

2.  Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver.

Authors:  Lei Liu; Bolei Dai; Ruixue Li; Zheng Liu; Zhihong Zhang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 3.  Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.

Authors:  Zhuoyan Liu; Xuan Liu; Jiaxin Liang; Yixin Liu; Xiaorui Hou; Meichuan Zhang; Yongyin Li; Xiaotao Jiang
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.